Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
oleh: M. Brausi, F.Calais da Silva, P. Ferrari, G. Ferrari, S. Rabito
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-10-01 |
Deskripsi
No description available for this item.